Seriously ill and terminal patients in Hong Kong could benefit from faster ‘1+’ drug approval system, health secretary says
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Secretary for Health Lo Chung-mau says new regulatory rules will allow foreign medical innovators to bring products to Hong Kong for trials.